v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
No Par, Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period at Dec. 31, 2024 $ 21,525 $ 98,178 $ (63,153) $ (13,500)
Balance at beginning of period (in shares) at Dec. 31, 2024   12,222,881    
Net income (loss) 522   522  
Issuance of warrants 1,924 $ 1,924    
Stock-based compensation expense 15 15    
Other comprehensive income (loss) 1,599     1,599
Balance at end of period at Mar. 31, 2025 25,585 $ 100,117 (62,631) (11,901)
Balance at ending of period (in shares) at Mar. 31, 2025   12,222,881    
Balance at beginning of period at Dec. 31, 2025 8,966 $ 100,158 (81,591) (9,601)
Balance at beginning of period (in shares) at Dec. 31, 2025   12,222,881    
Net income (loss) 2,622   2,622  
Issuance of common stock 14,000 $ 14,000    
Issuance of common stock, Shares   14,000,000    
Common stock issuance costs (252) $ (252)    
Stock-based compensation expense 13 13    
Other comprehensive income (loss) (159)     (159)
Balance at end of period at Mar. 31, 2026 $ 25,190 $ 113,919 $ (78,969) $ (9,760)
Balance at ending of period (in shares) at Mar. 31, 2026   26,222,881